Mulder J, Tan H K, Bellomo R, Silvester W
Department of Intensive Care, Austin Hospital, Melbourne, Australia.
Int J Artif Organs. 2003 Oct;26(10):906-12. doi: 10.1177/039139880302601006.
Thrombocytopenia is a common finding in patients in the intensive care unit receiving continuous renal replacement therapy (CRRT). It is unknown if the hemofilter itself contributes to the platelet loss.
To measure the direct effect of the hemofilter on platelet counts during CRRT.
Prospective, observational study.
Intensive care unit of a University hospital.
Critically ill patients with acute renal failure receiving CRRT.
Two samples of blood were drawn simultaneously, pre-filter and post-filter, and analyzed for platelet count. A correction factor was applied to the post-filter platelet count to adjust for the hemoconcentrating effect of net ultrafiltration.
Forty-eight sets of paired data from 22 patients were studied. There was a small but significant decrease in mean platelet count across the hemofilter. The mean platelet count drop was 2.32 x 10(9)/L (s.e. 1.06, p = 0.0487, 95% CI (0.01, 4.62)). Blood flow was strongly related to degree of platelet loss, with a decreased loss of 0.07 x 10(9)/L for every ml/min increase in blood flow (p = 0.015). There was no overall decrease in concurrently measured red cell counts across the hemofilter. However, there was a machine-specific affect on red cell loss (p < 0.0001). The total calculated daily platelet loss across the filter was 625 x 10(9) cells.
The hemofilter may contribute to the thrombocytopenia seen during CRRT, by means of either destruction or retention of platelets during passage. This affect appears attenuated by higher blood flows. This information is useful in the assessment of a low platelet count in patients receiving CRRT.
血小板减少是接受持续肾脏替代治疗(CRRT)的重症监护病房患者的常见表现。血液滤过器本身是否导致血小板丢失尚不清楚。
测量CRRT期间血液滤过器对血小板计数的直接影响。
前瞻性观察研究。
大学医院重症监护病房。
接受CRRT的急性肾衰竭重症患者。
在滤器前和滤器后同时采集两份血样,分析血小板计数。对滤器后血小板计数应用校正因子,以校正净超滤的血液浓缩效应。
研究了来自22例患者的48组配对数据。血液滤过器前后平均血小板计数有小幅但显著的下降。平均血小板计数下降2.32×10⁹/L(标准误1.06,p = 0.0487,95%可信区间(0.01, 4.62))。血流量与血小板丢失程度密切相关,血流量每增加1 ml/min,血小板丢失减少0.07×10⁹/L(p = 0.015)。血液滤过器前后同时测量的红细胞计数总体上没有下降。然而,对红细胞丢失存在机器特异性影响(p < 0.0001)。滤器每日计算的血小板总丢失量为625×10⁹个细胞。
血液滤过器可能通过在血小板通过期间的破坏或滞留导致CRRT期间出现的血小板减少。较高的血流量似乎可减轻这种影响。该信息有助于评估接受CRRT患者的低血小板计数。